Design Therapeutics, Inc.

NASDAQ:DSGN

Biotechnology

Healthcare
$9.47 +1.59%

+$0.19 today

Market cap
$606.42M
Beta
1.66
P/E (TTM)
-10.7
EPS (TTM)
-$1.13
52W Low $3.33High $17.25

Volume 0.32M

Average 0.74M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$79.47M

FY 2025 · Annual

Net Income

-$69.79M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0466K537K596K622K
Gross Profit0(466K)(537K)(596K)(622K)
Gross Margin—————
Research & Development24.78M48.61M57.06M44.35M59.13M
Selling, General & Admin11.05M18.98M21.13M18.03M20.34M
Operating Expenses35.83M67.13M77.65M61.79M78.85M
Depreciation & Amortization129K466K537K596K622K
EBITDA(35.4M)(62.84M)(66.33M)(48.99M)(69.17M)
EBITDA Margin—————
Operating Income(35.83M)(67.59M)(78.19M)(62.38M)(79.47M)
Operating Margin—————
Interest Income00012.8M9.68M
Interest Expense00000
Other Income / Expenses298K4.29M11.33M12.8M9.68M
Income Before Tax(35.53M)(63.31M)(66.86M)(49.59M)(69.79M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(35.53M)(63.31M)(66.86M)(49.59M)(69.79M)
Net Margin—————
EPS (Basic)(0.77)(1.14)(1.19)(0.88)(1.22)
EPS (Diluted)(0.77)(1.14)(1.19)(0.88)(1.22)
Weighted Avg Shares45.94M55.71M55.98M56.59M57.33M
Weighted Avg Shares (Diluted)45.94M55.71M55.98M56.59M57.33M

DSGN Earnings Waterfall · TTM

NASDAQ:DSGN · Revenue to Net Income

Key Ratios

EPS$-1.20
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-6.6
P/S Ratio0.0

Analysis

$0 of revenue converted into -$69.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.20, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
EFFECTEFFECT filingNov 12, 2026
424B5424B5 filingNov 4, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
S-3S-3 filingNov 4, 2026

How much revenue does DSGN generate?

Design Therapeutics, Inc. (DSGN) reported $0.00 of revenue in fiscal 2025.

Is DSGN profitable?

Design Therapeutics, Inc. (DSGN) reported -$69.79M of net income.